Uncategorized
VIDEO: Co-founder of Novaliq gives business update
LAS VEGAS — At the Ophthalmology Innovation Summit, Bernhard Günther, managing director, CEO and co-founder of Novaliq, shares recent business updates, including plans for entering into a phase 2 clinical trial on CyclASol (cyclosporine solution) in 2016.